Prosecution Insights
Last updated: November 20, 2026

Jessica N Worsham, USPTO Patent Examiner

Listed by the USPTO as WORSHAM, JESSICA N

Tech Center 1600 • Art Units: 1615

This examiner grants 56% of resolved cases

Analysis

WORSHAM, JESSICA N is assigned to tech center 1600 and art unit 1615. The record includes 757 resolved cases, with an allowance rate of 56.5% and a median time to allowance of 1081 days. The volume supports using the outcome as a meaningful historical reference, while the allowance rate indicates that prosecution results are mixed.

The interview lift is 56.4%, making interviews a prominent strategic option in this record. Counsel may prepare focused interview agendas alongside written responses, particularly where claim amendments or technical distinctions require clarification. The listed companies are Harmony Foods LLC, Massachusetts Institute of Technology, and P Tech LLC. The listed firms are BIRCH STEWART KOLASCH & BIRCH, LLP, SUGHRUE MION, PLLC, and BakerHostetler.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

56.5%
Allow Rate
-3.5% vs TC avg
812
Total Applications
+56.4%
Interview Lift
1081
Avg Prosecution Days
Based on 757 resolved cases, 2023–2026

Rejection Statute Breakdown

1.2%
§101 Eligibility
13.4%
§102 Novelty
42.0%
§103 Obviousness
25.8%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
19647159 PALATABLE CHEWABLE COMPOSITIONS WITH IMPROVED TASTE MASKING Non-Final OA Harmony Foods LLC
19443532 PALATABLE CHEWABLE COMPOSITIONS WITH IMPROVED TASTE MASKING Non-Final OA Harmony Foods LLC
18714142 POLY(BETA-AMINO ESTER) MICROPARTICLES FOR MICRONUTRIENT FORTIFICATION Non-Final OA Massachusetts Institute of Technology
19397956 TREATMENT OF BLOOD LOSS AT TISSUE WOUND Final Rejection P Tech, LLC
17916180 IMPLANT DEVICES AND METHODS FOR TREATMENT OF CERVICAL CANCER Non-Final OA Washington University
18291525 BIOMATERIALS FOR EMBOLIZATION AND DRUG DELIVERY Non-Final OA Regents of the University of Minnesota
18684728 DIRECT TABLETING AUXILIARY COMPOSITION Non-Final OA BASF SE
18560900 SEED TREATMENT COMPOSITIONS Non-Final OA SYNGENTA CROP PROTECTION AG
18701581 TREATMENT OF CANCER AND AUTOIMMUNE DISORDERS USING NANO POLYMERS OF HISTONE DEACETYLASE INHIBITORS Non-Final OA University of Virginia Patent Foundation
18879145 DISPERSION AND COSMETIC CONTAINING SAME Non-Final OA SHIN-ETSU CHEMICAL CO., LTD.
17926040 METHODS AND COMPOSITIONS FOR TREATING A FIBROTIC DISEASE Non-Final OA BETH ISRAEL DEACONESS MEDICAL CENTER
18741628 METHODS OF FORMING STORAGE STABLE MIXTURES Non-Final OA DSM IP Assets B.V.
18261762 METHODS OF SELECTIVELY PROMOTING GASTROINTESTINAL MICROBIAL GROWTH Final Rejection DSM IP Assets B.V.
18888697 IONIZABLE LIPIDOID COMPOSITIONS AND THERAPEUTIC USES THEREOF Non-Final OA Flagship Pioneering Innovations VII, LLC
18034969 NON-CATIONIC SOFT POLYPHENOL NANOCAPSULES FOR EFFECTIVE SYSTEMIC DELIVERY OF SMALL INTERFERING RNA (siRNA) FOR CANCER TREATMENT Final Rejection Purdue Research Foundation
18005240 MEDICAL DEVICES HAVING ANTI-MICROBIAL PROPERTIES AND METHODS FOR MAKING THE SAME Non-Final OA Hollister Incorporated
18865572 PLANT DISEASE CONTROL METHOD Non-Final OA SUMITOMO CHEMICAL COMPANY, LIMITED
18849372 Lipid Based Nanoparticles for Targeted Gene Delivery to the Brain Non-Final OA National Research Council of Canada
17927168 METAL-ORGANIC FRAMEWORKS DELIVER SMALL MOLECULES AND BIOMACROMOLECULES FOR CANCER IMMUNOTHERAPY Non-Final OA The University of Chicago
18006630 ADHESIVE, EXTRUDABLE ABOVE-GROUND TERMITE BAIT AND METHODS FOR MANUFACTURING SAME Non-Final OA DOW AGROSCIENCES LLC

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Jessica N Worsham's allowance rate?

56.5% of resolved applications examined by Jessica N Worsham were allowed (757 resolved cases), compared with 43.8% across Art Unit 1615 over the last five years.

Does an interview help with examiner Jessica N Worsham?

This examiner's interview lift is +56.4 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Jessica N Worsham take to allow a patent?

Applications allowed by Jessica N Worsham took 1,081 days on average from filing to allowance.

Which art unit does examiner Jessica N Worsham work in?

Jessica N Worsham examines applications in Art Unit 1615 in Tech Center 1600 (Biotechnology & Pharmaceuticals).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month